BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8896057)

  • 1. New bisphosphonates for the treatment of osteoporosis: concerns and hopes.
    Reginster JY
    Rev Rhum Engl Ed; 1996; 63(7-8):461-4. PubMed ID: 8896057
    [No Abstract]   [Full Text] [Related]  

  • 2. Bisphosphonates in the treatment of osteoporosis. Principles and efficacy.
    Papapoulos SE
    Ann Med Interne (Paris); 2000 Oct; 151(6):504-10. PubMed ID: 11104931
    [No Abstract]   [Full Text] [Related]  

  • 3. Bisphosphonates in the treatment of osteoporosis.
    Hochberg MC
    Rev Rhum Engl Ed; 1997 Jun; 64(6 Suppl):53S-55S. PubMed ID: 9273939
    [No Abstract]   [Full Text] [Related]  

  • 4. [The successful development of bisphosphonates in the therapy of osteoporosis].
    Fassbender WJ; Stumpf UC; Kurth A
    Med Klin (Munich); 2006 Jun; 101 Suppl 1():6-14. PubMed ID: 16826363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bisphosphonates and combined treatments osteoporosis].
    Rizzoli R; Ferrari S
    Rev Med Suisse; 2005 Oct; 1(35):2266, 2269-71. PubMed ID: 16268449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New bisphosphonates and trends in drug therapy for osteoporosis: preface.
    Matsumoto T
    Clin Calcium; 2009 Jan; 19(1):9. PubMed ID: 19170268
    [No Abstract]   [Full Text] [Related]  

  • 7. [Evidence-based assessment of therapeutic agents of osteoporosis. Bisphosphonates, SERM and basic therapy in front].
    MMW Fortschr Med; 2003 Jul; 145(27-28):63. PubMed ID: 14587198
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug insight: the use of bisphosphonates for the prevention and treatment of osteoporosis in men.
    Brown SA; Guise TA
    Nat Clin Pract Urol; 2007 Jun; 4(6):310-20. PubMed ID: 17551535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination and sequential therapy with PTH and bisphosphonates.
    Bauer DC
    J Musculoskelet Neuronal Interact; 2004 Dec; 4(4):407. PubMed ID: 15758282
    [No Abstract]   [Full Text] [Related]  

  • 10. Selected therapy-related clinical research topics in osteoporosis.
    Bigos ST
    J Pediatr Endocrinol Metab; 2003 May; 16 Suppl 3():687-90. PubMed ID: 12795372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New development in bisphosphonate treatment. Bisphosphonates for the treatment of glucocorticoid-induced osteoporosis].
    Soen S
    Clin Calcium; 2009 Jan; 19(1):44-53. PubMed ID: 19122264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bisphosphonates in the prevention and treatment of glucocorticoid-induced osteoporosis.
    Blair MM; Carson DS; Barrington R
    J Fam Pract; 2000 Sep; 49(9):839-48. PubMed ID: 11032210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical evaluation of novel bisphosphonate dosing regimens in osteoporosis: the role of comparative studies and implications for future studies.
    Cosman F; Borges JL; Curiel MD
    Clin Ther; 2007 Jun; 29(6):1116-27. PubMed ID: 17692726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A once-a-year intravenous treatment of osteoporosis in postmenopausal women: implications for the clinical nurse specialist.
    O'Malley P
    Clin Nurse Spec; 2008; 22(4):169-71. PubMed ID: 18596484
    [No Abstract]   [Full Text] [Related]  

  • 15. [Bisphosphonates in the treatment of osteoporosis].
    Díaz López B; Gómez Alonso C
    Rev Clin Esp; 2000 Jun; 200(6):327-9. PubMed ID: 10953588
    [No Abstract]   [Full Text] [Related]  

  • 16. [Bisphosphonate therapy in osteoporosis. Inhibition of trabecular perforation by aminobisphosphonate].
    Wüster C; Heilmann P
    Fortschr Med; 1997 Oct; 115(29):37-42. PubMed ID: 9445833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New development in bisphosphonate treatment. Review of effect on bone metabolism by minodronic acid in primary osteoporosis].
    Fukunaga M
    Clin Calcium; 2009 Jan; 19(1):63-73. PubMed ID: 19122266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
    Pazianas M; Miller P; Blumentals WA; Bernal M; Kothawala P
    Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Osteoporosis therapy. Bisphosphonates compared].
    MMW Fortschr Med; 2003 Mar; 145(13):60. PubMed ID: 15101545
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of bisphosphonates in the treatment of systemic osteoporosis].
    Rodionova SS; Zatsepin ST; Shvets VN; Matkovskaia TA
    Ortop Travmatol Protez; 1989 Mar; (3):51-6. PubMed ID: 2740116
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.